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Introduction 
Intestinal coccidiosis, a contagious enteritis 
caused mainly by infection with the 
protozoan parasite Eimeria spp., occurs 
universally, affecting both domesticated and 
wild mammals. Overt disease with diarrhea, 
dysentery and even death, or chronic 
infection with symptoms of malnourishment, 
or subclinical infection with diminished 
weight gain, may be present within a group 
of affected animals. The disease is most 
important where animals are housed or 
confined in small areas-the situation found 
in large scale management systems and in 
zoologie al collections. 
Overt disease caused by Eimeria spp. was 
repeatedly diagnosed at Tierpark Hellabrunn 
in many species of wild ruminants. As 
previous methods of therapeutic treatment of 
the affected cases did little to reduce the 
overall occurrence of disease, and initial 
trials to reduce oocyst excretion by 
prophylactie use of amprolium in a dosage 
of 40 mg/kg body weight were not 
satisfactory,22 a study of the prophylactic 
effects of monensin was undertaken in the 
following field trial. 
The anticoccidial compound monensin is 
an ionophore antibiotic produced as a 
fermentation product of Streptomyces 
cinnamonensis 1 o. It has been proven to be 
effective against enteric coccidiosis in 
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poultry l9, catde,6.13 and sheep.1.7·11.12.14 
Monensin affects the coccidian life cycle at 
the first generation schizont stage. 19 In 
mammals, monensin causes the reduction or 
complete cessation of oocyst production at 
various levels. For prophylactic use the 
following dose levels are recommended. 
Lambs: 10-20 mg/kg sheep fattening ration 
resulting in approximately 0.8-1.6 mg/kg body 
weight. 2.3. 7 .8.14.21 
Cattle: 1 mg/kg body weight. 6.13 
In some species problems occurred with 
unpalatability if monensin was included in 
the ration at too high a level. 3.6 Levels of 
monensin of over 150 mg/kg medicated 
pellets, was refused by chamois, mouflon 
and ibex but accepted by some antelope and 
gazelle species. 
There have been reports of toxicity of 
monensin in horses, lambs, catde and deer. 
Equine species are more sensitive to 
monensin than are ruminants, showing toxie 
effects on the mitochondria of the liver and 
heart. Death has occurred in lambs given 
monensin at a dosage rate of 8 mg/kg body 
weight and the LD50 of monensin in cattle is 
reported as 26.6 mg/kg body 
weight. 1.4.5.9.15.16.18.20 
Materials and Methods 
During 1980-1982 fecal sampies from wild 
ruminants were collected every week in 
Tierpark Hellabrunn and examined for 
coccidia oocysts. 
The following groups of animals were 
subject to strict parasitological supervision: 
12 Chamois Rupicapra rupicapra 
14 Markhor Capra /alconeri 
7 Dorcas gazelle Gazella dorcas 
9 Springbok Antidorcas marsupialis 
T emporarily included in the parasitological 
examinations were fecal sampies of: 
16 European mouflon Ovis ammon musimon 
16 Alpine ibex Capra ibex ibex 
11 Nubian ibex Capra ibex nubiana 
12 Mountain gazelle Gazella gazella 
4 Impala Aepyceros melampus 
The sampies were processed by the 
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Figure 1. Fresh not sporulated Eimeria oocysts shed by chamois 
a E. alpina 
b E. riedmuel/eri 
c E. rup,caprae 
d E. yakimoff-matschoulskyi 
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ZnCl2-NaCl flotation technique (specific 
gravity: 1.3 g/cm3). One loop of the fluid 
surface was covered with a 18x18 mm 
coverglass and one line through the center 
was examined for coccidia with 160-fold 
magnification. A semiquantitative counting 
technique was applied using the following 
key: 
o : no oocysts 
+ : oocysts hard to find «10) 
+ + : oocysts easy to find (11-30) 
+ + + oocysts in every microscopial 
view (>30) 
Eimeria spp. of chamois were 
differentiated according to morphological 
characteristics. 17 Coccidia of other species 
could not be differentiated, as most of them 
are not described in the literature and their 
specificity has not been investigated. 
Furthermore, transmission of coccidia 
species from one species of ruminant to 
another could not be excluded. 
The anticoccidial antibiotic monensin was 
mixed into pelleted food in concentrations of 
75, 100 and 150 mg/kg. The medicated 
pellets were fed at a level of approximately 
100g/lOkg body weight, resulting in an 
effective dosage of 0.75, 1.0 and 1.5 
monensin/kg body weight. Besides medicated 
pellets, hay and green forage was fed ad lib. 
Additionally, according to season, leafed 
branches, vegetables, fruit, silage, brewers 
grains and a mixture of concentrated foods 
without medication were offered. 
Results 
All species of ruminants from which fecal 
sampies were collected, showed infection 
with Eimeria spp. before monensin-medicated 
pellets were fed. The coccidia of chamois 
were identified as: Eimeria alpina (Fig. 1a), 
E riedmue!lerie (Hg. 1b), E rupicapra (Fig. 
1c) and Eyakimoff-matschoulskyi (Hg. 1d). 
The percentage of E alpina oocysts was 
high in feces of chamois with clinical 
symptoms. High los ses of 4-6. month old 
animals as a result of intestinal coccidiosis 
were observed in chamois. The animals 
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showed inappetence, dull appearance, 
diarrhea with soiling of the hindquarters and, 
in some cases, edema of the throat region 
(Fig. 2). 
The herd of chamois was kept on an 
4,240 m2 area and therefore individual 
therapy with sulfanomides was not always 
possible. T 0 avoid further losses in the 
summer of 1980 monensin as given at a 
dosage rate of 150 mg/kg pelleted food, 
resulting in an effective dosage rate of 1.5 
mg/kg body weight. In spite of individual 
variation in the consumption of the medicated 
food, the number of expelled oocysts 
decreased and after four weeks, all fecal 
sampies were negative for coccidia (Fig. 3a). 
In Nov. of 1980, the medication of the 
pelleted food was terminated and immediately 
an increasing number of oocysts was 
observed in the feces. The young stock 
showed clinical symptoms of coccidiosis and 
required chemotherapy (Fig. 3a). 
Good results were obtained with parenteral 
application of Theracanzan" (l00ml contains 
33.4g Sulfadimethoxin) 1-2ml!lOkg body 
weight and simultaneous oral application of 
Socatylb (100g contains SOg Formo-
Sulfathiazol) at a dosage rate of 4g/lOkg 
body weight over a period of 3-5 days. Again 
monensin medicated pellets were fed at the 
same concentration, and the shedding of 
oocysts ceased. 
Same animals ate less medicated food 
when monensin was added at the rate of 
150 mg/kg pellets, resulting in reduced 
weight gain. To increase the palatability of 
the medicated food, the concentration of 
monensin was reduced to 75 mg/kg pellets 
in the summer of 1981. All the animals 
accepted the offered ration, but again oocyst 
counts in the feces increased and after two 
months diarrhea occurred, caused by 
intestinal coccidiosis requiring individual 
chemotherapy (Hg. 3b). Increasing the 
percentage of monensin in the pellets to 100 
mg/kg caused a sharp reduction in the 
oocyst counts and clinical symptoms 
disappeared. Although monensin was fed 
Figura 2. Young chamois suffering Irom intestinal coccidiosis showing eduma 01 the throat region . 
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continuously in the ration, in the springtime 
of 1982 the number of oocysts shed by the 
young stock increased, but neither maximal 
oocyst counts nor clinical symptoms were 
observed, nor was any chemotherapy 
necessary (Fig. 3b). 
Similar results were seen in the other 
species of ruminants fed with monensin-
medicated rations, Le. palatability of 150 
mg/kg medicated food was lessened, but 
oocyst excretion terminated. Mouflon and 
ibex were especially resistant to the 
medicated pellets, whereas antelopes and 
gazelIes accepted the medicated ration. The 
use of monensin at the rate of 75 mg/kg 
pellets resulted again in increased oocyst 
counts, whilst 100 mg/kg medicated pellets 
resulted in good effects, both in regard to 
palatability and to coccidiostatic efficiency. 
Ouring the 3-year period of using monensin, 
no los ses by intoxication or secondary 
effects, or reduced fertility could be 
observed. 
Discussion 
Oata described in the literature conceming 
the prophylactic use of monensin in 
ruminants cannot be compared with our 
results without reservation. According to our 
experience, feeding monensin at the rate of 
1 mg/kg body weight, given over periods up 
to 10 months is effective in controlling 
coccidisis of wild ruminants under certain 
conditions in zoological gardens. This dosage 
approaches the 0.8-1.6 mg/kg body weight 
recommended for monensin in lambs and 
1.0 mg/kg in calves.2.3·6.7.8.13.14.21 In contrast 
to the experience in lambs and cattle, 
unpalatability of the medicated ration must 
be considered in many species of zoo 
ruminants. The best results were obtained 
by offering the medicated ration at a rate of 
100 mg/kg pellets. It should be noted that 
individually in all species, intake of the 
medicated feed could not be controlled, 
particularly if animals were kept in groups in 
large enclosures. It therefore cannot be 
discounted that some of the animals had a 
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higher intake of monensin than the average 
of 1 mg/kg body weight, although no losses 
by monensin toxicity, nor secondary effects, 
nor reduced fertility could be observed during 
the 3-year period. 
Of the five species of coccidia to affect 
wild chamois in the alpine region, four 
species were identified in our stock. 1 7 This 
can be explained by the fact that the 
breeding stock of the herd was captured in 
the wild. 
The fact that even three years of 
permanent use of monensin could not 
eliminate coccidia in the ruminants may be 
desirable because it results in minor infection 
of the stock, aiding in developing immunity 
without clinical symptoms, as is weil known 
in poultry. 1 7 The drug monensin proved to 
be suitable for control of coccidiosis in 
various species of ruminants kept in Tierpark 
Hellabrunn. Development of resistance-as 
observed in many other coccidiostatic 
compounds-is not reported for monensin so 
far. This problem could be avoided by 
changing the coccidiostatic drug from time to 
time. 
Summary 
Intestinal coccidiosis of wild ruminants in 
Tierpark Hellabrunn caused frequent losses 
of young stock, particularly in chamois. 
Individual chemotherapy with sulfonamides 
was successful, but could not solve the 
problem in groups of animals, kept on large 
areas. 
The pelleted food was medicated with 
monensin at three levels, 75, 100 and 150 
mg/kg, and was offered over periods of 5-10 
months in effective doses of about 0.75, 1.0 
and 1.5 mg monensin/kg body weight. 
Satisfactory results were obtained when 
feeding 1 mg/kg body weight in nine species 
of wild ruminants, with regard to 
coccidiostatic effect and palatability of the 
medicated food. OuTing three years of use of 
monensin, no toxicities nor symptoms of 
incompatability were observed. 
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